E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedMachine draft
Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections.
Barnes, Eleanor, Flanagan, Peter, Brown, Anthony et al. · The Journal of infectious diseases · 2010 · DOI
Quick Summary
In 2010, researchers tested 230 people with HIV or hepatitis C to see if they carried a virus called XMRV, which had recently been suggested as a possible cause of chronic fatigue syndrome. They found no trace of XMRV in blood samples or immune cells, and people's immune systems showed no signs of having fought off this virus. This suggested that XMRV was not common in people with these blood-borne infections.
Why It Matters
Early reports linked XMRV to chronic fatigue syndrome, generating significant hope but also concern among ME/CFS patients. This negative finding from a well-characterized clinical cohort provided important evidence questioning the initial XMRV-ME/CFS association, informing ongoing discussions about viral contributions to the disease and the reliability of initial claims.
Observed Findings
- XMRV was undetectable in plasma samples from 230 patients with HIV-1 or hepatitis C by PCR targeting gag and env regions.
- XMRV was undetectable in peripheral blood mononuclear cells by the same PCR methods.
- No T cell responses to XMRV Gag were detected by ex vivo gamma interferon ELISPOT assay.
- XMRV was not enriched in patients with blood-borne or sexually transmitted infections from UK and Western European cohorts.
Inferred Conclusions
- XMRV is not prevalent in immunocompromised patients with blood-borne infections in Western Europe and the UK, despite earlier suggestions of 3.7% prevalence in healthy populations.
- The frequent detection of XMRV in some previous studies may reflect methodological differences, contamination, or population-specific patterns rather than a universal presence of the virus.
- The apparent association between XMRV and chronic fatigue syndrome reported in earlier work warrants critical reexamination.
Remaining Questions
- Why did earlier studies report XMRV detection in ME/CFS patients if the virus appears absent or rare in other populations?
- Would direct testing of ME/CFS patients in this study have yielded different results than indirect inference from HIV/hepatitis C cohorts?
What This Study Does Not Prove
This study does not prove that XMRV has no role in ME/CFS, as it did not directly test ME/CFS patients—it only examined people with HIV and hepatitis C. The failure to detect XMRV in this specific population does not exclude its presence in other populations or disease contexts. It also does not establish whether XMRV detection methods used in earlier studies were reliable or valid.
Tags
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionExploratory OnlyMixed Cohort
Metadata
- DOI
- 10.1086/657167
- PMID
- 20936982
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →